Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. TLTFF


Primary Symbol: V.TLT

Healthcare Medical Devices
Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Theralase Technologies Inc. > Potential US election impact on the FDA?
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(408)
•••
Comment by skier59on Nov 07, 2024 6:20pm
138 Views
Post# 36302103

RE:RE:RE:Potential US election impact on the FDA?

RE:RE:RE:Potential US election impact on the FDA?Yeah, with the recent win by those MAGA's, I'm concerned things will come to a temporary standstill.
I was thinking about it yesterday morning, but I decided I wouldn't discuss it here unless others started it.

JFK Jr has said he intends to clean house at the FDA, and we all know what Musk has said he plans to do to the USA Govenment employees. These FDA employees are more focused on their short/long term futures than anything relating to what concerns us.

I hope I'm wrong.


charlierock wrote:
3Crows wrote: Considering Robert F. Kennedy Jr. is a radical anit-vaccine proponent, I'm assuming yes.

I was having the same concerns. Right now it's an unknown. All I can say is TLT better get BTD and hopefully AA soon because that RFK is a wacko. We need the FDA  to do its job unhindered.


<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities